{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:09:36Z","timestamp":1790165376653,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jneuroim.2019.577110","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:18:01Z","timestamp":1573039081000},"page":"577110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD"],"prefix":"10.1016","volume":"338","author":[{"given":"Giannina","family":"Arru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio R.","family":"Zarbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gajofatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni A.","family":"Deiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo A.","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Pietro","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jneuroim.2019.577110_bb0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1352458513494957","article-title":"Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study","volume":"20","author":"Arru","year":"2014","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.jneuroim.2019.577110_bb0010","article-title":"Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"3","author":"Arru","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.jneuroim.2019.577110_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaut.2013.01.006","article-title":"Natural autoantibodies in the physiology and pathophysiology of the immune system","volume":"41","author":"Avrameas","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2019.577110_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.micron.2019.02.005","article-title":"Cross-reactivity between myelin oligodendrocyte glycoprotein and humanendogenous retrovirus W protein: nanotechnological evidence for the potential trigger of multiple sclerosis","volume":"120","author":"De Luca","year":"2019","journal-title":"Micron."},{"issue":"7745","key":"10.1016\/j.jneuroim.2019.577110_bb0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis","volume":"566","author":"Jakel","year":"2019","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.jneuroim.2019.577110_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis\u202f: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.jneuroim.2019.577110_bb0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ana.23970","article-title":"Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation","volume":"74","author":"Kremer","year":"2013","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jneuroim.2019.577110_bb0040","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders","volume":"75","author":"Lopez-Chiriboga","year":"2018","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.jneuroim.2019.577110_bb0045","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2019.577110_bb0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5114\/ceji.2018.81354","article-title":"Natural antibodies \u2013 facts known and unknown","volume":"43","author":"Palma","year":"2018","journal-title":"Cent. Eur. J. Immunol."},{"issue":"14","key":"10.1016\/j.jneuroim.2019.577110_bb0055","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1073\/pnas.94.14.7583","article-title":"Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis","volume":"94","author":"Perron","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jneuroim.2019.577110_bb0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2019.577110_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.jneuroim.2019.577110_bb0070","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.4049\/jimmunol.176.12.7636","article-title":"The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14\/TLR4 and promotes Th1-like responses","volume":"176","author":"Rolland","year":"2006","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.jneuroim.2019.577110_bb0075","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/1352458510376956","article-title":"Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis","volume":"16","author":"Sotgiu","year":"2010","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2019.577110_bb0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819303595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819303595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:35:22Z","timestamp":1759048522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572819303595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":16,"alternative-id":["S0165572819303595"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577110","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577110"}}